author-photo

Katie Twigger

Institute of Cancer Research

18

Papers

1014

Citations

Citation Trend

Filter By

Papers (11) Sort By

Journal Conference Others

Antiviral antibody responses to systemic administration of an oncolytic RNA virus: the impact of standard concomitant anticancer chemotherapies.

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
A phase I study of the combination of intravenous reovirus type 3 Dearing and gemcitabine in patients with advanced cancer.

2011 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (93)
Two-Stage Phase I Dose-Escalation Study of Intratumoral Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients with Advanced Cancers

2010 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (93)
REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients with Advanced Cancer

2010 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (117)
Cyclophosphamide Facilitates Antitumor Efficacy against Subcutaneous Tumors following Intravenous Delivery of Reovirus

2008 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (150)
Escherichia coli nitroreductase plus CB1954 enhances the effect of radiotherapy in vitro and in vivo.

2008 Gene Therapy
Show All
- Source
- Cite
- Save
Citations (12)
Enhanced in vitro and in vivo cytotoxicity of combined reovirus and radiotherapy

2008 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (89)
Phase I trial of intratumoral administration of reovirus type 3 with radiation in patients with advanced malignancies

2007 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Reovirus and other oncolytic viruses for the targeted treatment of cancer

2006 Targeted Oncology
Show All
- Source
- Cite
- Save
Citations (10)
A phase I study of a wild-type reovirus (Reolysin) given intravenously to patients with advanced malignancies.

2005
Show All
- Source
- Cite
- Save
Citations (1)